Outset Medical, Inc. (OM)
| Market Cap | 2.55B |
| Revenue (ttm) | 79.14M |
| Net Income (ttm) | -134.57M |
| Shares Out | 46.31M |
| EPS (ttm) | -3.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,762,668 |
| Open | 54.67 |
| Previous Close | 53.76 |
| Day's Range | 52.70 - 55.16 |
| 52-Week Range | 36.03 - 66.96 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 63.00 (+14.6%) |
| Est. Earnings Date | Nov 4, 2021 |
About OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Financial Performance
In 2020, Outset Medical's revenue was $49.94 million, an increase of 231.18% compared to the previous year's $15.08 million. Losses were -$121.49 million, 77.9% more than in 2019.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for Outset Medical stock is "Buy." The 12-month stock price forecast is 63.00, which is an increase of 14.59% from the latest price.
News
Warren Buffett's Largest Healthcare Stock Investment
There are several healthcare companies in Berkshire Hathaway's portfolio, but only one in its top 10 holdings.
1 Beaten-Down Healthcare Stock to Put on Your Radar
This innovative company is well off its highs and could be worth a look.
Outset Medical to Present at Upcoming September Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical Reports Second Quarter 2021 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...
Outset Medical Names Nabeel Ahmed as Chief Financial Officer
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.
Outset Medical to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical CFO To Step Down; Sees 109% Revenue Growth In Q2
Medical technology company Outset Medical Inc's (NASDAQ: OM) Chief Financial Officer, Rebecca Chambers, is set to resign from the position to pursue other opportunities, effective July 16, 2021. Outset ...
Outset Medical Announces Departure of CFO and Appointment of Nabeel Ahmed as Interim CFO
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical Welcomes Jean-Olivier Racine as Chief Technology Officer
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer. In t...
Health Tech Innovators Strive Health and Outset Medical Collaborate to Reinvent Kidney Care
SAN JOSE, Calif.--(BUSINESS WIRE)--Strive Health, the national leader in value-based kidney care, and Outset Medical, Inc. (Nasdaq: OM), a dialysis technology innovator, announced a collaboration to hel...
Satellite Healthcare and Outset Medical Announce Multi-Year Agreement to Increase Home Dialysis Penetration
SAN JOSE, Calif.--(BUSINESS WIRE)--Satellite Healthcare, a leading national not-for-profit kidney care company and Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-i...
Outset Medical to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical Appoints MedTech Executive Katie Szyman to Board of Directors
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, today a...
Outset Medical Joins Healthcare Innovation Coalition Focused on Shaping the Future of Home-Based Care
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq:OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, has joined Movi...
Outset Medical Reports First Quarter 2021 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...
Outset Medical to Present at BofA Securities 2021 Virtual Health Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical to Report First Quarter 2021 Financial Results on Wednesday, May 5, 2021
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ann...
Outset Medical Prices Equity Offering At $53.50 Per Share
Outset Medical Inc (NASDAQ: OM) has priced an underwritten public offering of 2.5 million common shares sold by the company and some 3.4 million shares sold by certain of its stockholders at $53.50 per ...
Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge
SAN JOSE, Calif.--(BUSINESS WIRE)--The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have named Outset Medical's Tablo Hemodialysis System® one of seven...
Outset Medical Announces Pricing of Primary and Upsized Secondary Public Offering
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ann...
Outset Medical Announces Primary and Secondary Offering of Common Stock
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ann...
Outset Medical Appoints Global Consumer Brand Builder Andrea Saia to Board of Directors
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), the medical technology company that pioneered the Tablo Hemodialysis System, a first-of-its-kind device to reduce the cos...
Outset Medical Reports Fourth Quarter and Full Year 2020 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...